GSK2332255B
| Code | Size | Price |
|---|
| TAR-T38780-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
GSK2332255B is a potent, selective TRPC3 and TRPC6 antagonist with IC 50 s of 5 nM and 4 nM for rat TRPC3 and rat TRPC6 . GSK2332255B shows ?100-fold selectivity for TRPC3/6 over other calcium-permeable channels.
CAS:
1366233-41-1
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
Kinya Seo, et al. Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy. Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1551-6.